Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

Compare more Cancer Research professors.

h-index148
i10-index697
Publications2,643
Citations108,140

Grants

7 total · 4 active

NIH #UM1TR004906

Center for Clinical and Translational Sciences

Active
Amount
$5M–$6M
Period
2024-07-242031-06-30
PIs
7

Awarded at UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON

NIH #T32CA009599

Training of Academic Surgical Oncologists

Active
Amount
$600K–$700K
Period
1994-05-252028-02-29
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA273168

Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold

Active
Amount
$500K–$600K
Period
2022-07-012027-06-30
PIs
3

Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

7 total · 4 active

NIH #UM1TR004906

Center for Clinical and Translational Sciences

Active
Amount
$5M–$6M
Period
2024-07-242031-06-30
PIs
7

Awarded at UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON

NIH #T32CA009599

Training of Academic Surgical Oncologists

Active
Amount
$600K–$700K
Period
1994-05-252028-02-29
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA273168

Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold

Active
Amount
$500K–$600K
Period
2022-07-012027-06-30
PIs
3

Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR

NIH #U01CA268813

A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)

Active
Amount
$500K–$600K
Period
2022-06-102027-05-31
PIs
4

Awarded at METHODIST HOSPITAL RESEARCH INSTITUTE

NIH #P30CA016672

15 Developmental Therapeutics

Amount
<$100K
Period
1996-08-282026-06-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #UM1CA186688

Texas EXperimental Cancer Therapeutics Network - TEX CTN

Amount
$5M–$6M
Period
2014-03-142023-02-28
PIs
5

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #U54CA224065

University of Texas PDX Development and Trial Center

Amount
$1M–$2M
Period
2017-09-302022-08-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Recent Public Signals

  1. New paper: Table 4 from &lt;i&gt;Post Hoc&lt;/i&gt; Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors2026-07-01
  2. New NIH award: Center for Clinical and Translational Sciences2024-07-24
  3. New NIH award: Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold2022-07-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

ORCID: 0000-0001-6816-6072

Professor Insights

Career Trajectory